HK1207656A1 - Albumin binding polypeptide - Google Patents

Albumin binding polypeptide

Info

Publication number
HK1207656A1
HK1207656A1 HK15108373.3A HK15108373A HK1207656A1 HK 1207656 A1 HK1207656 A1 HK 1207656A1 HK 15108373 A HK15108373 A HK 15108373A HK 1207656 A1 HK1207656 A1 HK 1207656A1
Authority
HK
Hong Kong
Prior art keywords
binding polypeptide
albumin binding
albumin
polypeptide
binding
Prior art date
Application number
HK15108373.3A
Other languages
English (en)
Chinese (zh)
Inventor
Caroline Ekblad
Joachim Feldwisch
Kyong-Hoon Ahn
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affibody Ab filed Critical Affibody Ab
Publication of HK1207656A1 publication Critical patent/HK1207656A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15108373.3A 2012-09-25 2015-08-28 Albumin binding polypeptide HK1207656A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261705223P 2012-09-25 2012-09-25
EP12185874 2012-09-25
PCT/EP2013/069946 WO2014048977A1 (fr) 2012-09-25 2013-09-25 Polypeptide liant l'albumine

Publications (1)

Publication Number Publication Date
HK1207656A1 true HK1207656A1 (en) 2016-02-05

Family

ID=46940383

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108373.3A HK1207656A1 (en) 2012-09-25 2015-08-28 Albumin binding polypeptide

Country Status (7)

Country Link
US (1) US10155792B2 (fr)
EP (1) EP2900688B1 (fr)
JP (2) JP6590695B2 (fr)
KR (1) KR102123457B1 (fr)
CN (2) CN104662035A (fr)
HK (1) HK1207656A1 (fr)
WO (1) WO2014048977A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ604805A (en) 2010-07-09 2014-09-26 Affibody Ab Polypeptides
WO2015091957A1 (fr) 2013-12-20 2015-06-25 Affibody Ab Polypeptide modifié liant l'albumine
BR112017014559A2 (pt) 2015-01-12 2018-05-15 Affibody Ab polipeptídeo de ligação de il-17a, proteína de fusão ou conjugado, complexo, polinucleotídeo que codifica um polipeptídeo, e, composição
KR102303744B1 (ko) * 2017-11-28 2021-09-16 주식회사 엘지화학 성장 호르몬을 포함하는 융합 단백질
CA3082369A1 (fr) * 2017-12-04 2019-06-13 The General Hospital Corporation Systeme d'enzyme redox extracellulaire pour soulager une maladie
KR102646845B1 (ko) * 2018-08-08 2024-03-14 주식회사 대웅제약 클로스트리파인을 이용한 지속형 인슐린 아날로그 복합체의 활성형 제조방법
KR102666154B1 (ko) * 2018-08-08 2024-05-20 주식회사 대웅제약 지속형 인슐린 아날로그 및 그 복합체
CN109776653B (zh) * 2018-11-26 2022-05-17 上海华新生物高技术有限公司 一种人血清白蛋白黏附肽及其应用
WO2021043757A1 (fr) 2019-09-02 2021-03-11 Biotest Ag Protéine du facteur viii à demi-vie accrue
EP3785726A1 (fr) 2019-09-02 2021-03-03 Biotest AG Protéine de facteur viii à demi-vie prolongée
US20220389066A1 (en) 2019-11-05 2022-12-08 Affibody Ab Polypeptides
US20230190881A1 (en) 2020-02-17 2023-06-22 Biotest Ag Subcutaneous administration of factor viii
US20240101605A1 (en) 2020-12-21 2024-03-28 Affibody Ab New polypeptide
WO2022171892A1 (fr) 2021-02-15 2022-08-18 Affibody Ab Nouveau polypeptide de liaison à her2
WO2023049747A1 (fr) * 2021-09-22 2023-03-30 Elanco Us Inc. Compositions enzymatiques lytiques de streptococcus suis et leurs procédés d'utilisation
AR128475A1 (es) 2022-02-08 2024-05-15 Affibody Ab Polipéptidos y proteínas de fusión con afinidad de unión por tslp

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
US6362225B1 (en) 1999-01-21 2002-03-26 George Andreakos Target therapies for treating common viral infections
JP2003518075A (ja) 1999-12-24 2003-06-03 ジェネンテック・インコーポレーテッド 生理活性化合物の消失半減期延長のための方法及び組成物
US20040001827A1 (en) 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US7288265B1 (en) 2000-10-16 2007-10-30 Lectec Corporation Treating viral infection at smallpox vaccination site
US7316819B2 (en) 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2005000222A2 (fr) 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Nouveaux procedes et nouvelles compositions pour une administration amelioree par voie muqueuse de peptides et de proteines
US20050282756A1 (en) 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US8093207B2 (en) 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
CA2659655A1 (fr) 2006-08-08 2008-02-21 Alan M. Fogelman Les salicylanilides renforcent l'administration par voie orale de peptides therapeutiques
CA2666511A1 (fr) 2006-10-11 2008-04-17 Ablynx N.V. Sequences d'acides amines se liant a des proteines seriques essentiellement independamment du ph, composes les comprenant et utilisations correspondantes
GB0724331D0 (en) * 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
CN104710518A (zh) * 2007-07-31 2015-06-17 阿菲博迪公司 新白蛋白结合组合物、方法及应用
EP2077272A1 (fr) 2007-12-21 2009-07-08 Affibody AB Librairies de polypeptides avec une structure d'échafaudage prédéterminée
EP3777831B1 (fr) 2008-03-26 2023-11-29 Oramed Ltd. Procédés et compositions pour l'administration orale de protéines
CN101294187B (zh) 2008-06-06 2013-07-31 暨南大学 一种缓释生物活性多肽的方法与应用
AU2009283821B2 (en) 2008-08-18 2014-05-29 Entera Bio Ltd. Methods and compositions for oral administration of proteins
WO2010054699A1 (fr) 2008-11-17 2010-05-20 Affibody Ab Conjugués de domaine de liaison d’albumine
ES2548030T3 (es) 2009-06-01 2015-10-13 Medimmune, Llc Moléculas con semividas prolongadas y usos de las mismas
NZ604805A (en) 2010-07-09 2014-09-26 Affibody Ab Polypeptides
US20120027058A1 (en) 2010-07-29 2012-02-02 The Regents Of The University Of Michigan Portable, wireless multi-channel impedance analyzer
DK3241558T3 (da) 2010-09-28 2021-04-26 Aegerion Pharmaceuticals Inc Højopløselige leptiner
WO2012112319A1 (fr) 2011-02-04 2012-08-23 Aegis Therapeutics, Llc Compositions de médicament peptidique biodisponible par voie orale et procédés associés
ES2732475T3 (es) 2011-07-08 2019-11-22 Aegerion Pharmaceuticals Inc Polipéptidos modificados por ingeniería genética que tienen una duración potenciada de la acción y una inmunogenicidad reducida
KR20140142298A (ko) 2012-03-28 2014-12-11 애피바디 에이비 경구투여
WO2015091957A1 (fr) 2013-12-20 2015-06-25 Affibody Ab Polypeptide modifié liant l'albumine

Also Published As

Publication number Publication date
KR102123457B1 (ko) 2020-06-16
US20150225464A1 (en) 2015-08-13
JP2018183171A (ja) 2018-11-22
CN104662035A (zh) 2015-05-27
KR20150058454A (ko) 2015-05-28
US10155792B2 (en) 2018-12-18
WO2014048977A9 (fr) 2014-05-08
EP2900688B1 (fr) 2017-02-22
JP6590695B2 (ja) 2019-10-16
JP2015530400A (ja) 2015-10-15
CN111763247A (zh) 2020-10-13
WO2014048977A1 (fr) 2014-04-03
EP2900688A1 (fr) 2015-08-05

Similar Documents

Publication Publication Date Title
HK1207656A1 (en) Albumin binding polypeptide
IL291571A (en) cx3cr1 binding polypeptides
HK1208707A1 (en) Cd3 binding polypeptides cd3
IL254652A0 (en) Unnatural albumin binding sites
IL240838A0 (en) Anti-3–lag binding proteins
IL238185B (en) Albumin variants
IL233689A0 (en) Albumin variants
PL2912054T3 (pl) Polipeptyd wiążący albuminę
GB201220474D0 (en) Polypeptides
HK1205524A1 (en) Engineered conformationally-stabilized proteins
HK1207657A1 (en) Her3 binding polypeptides her3
GB201418608D0 (en) Peridinin-chlorophyll binding proteins
HK1211952A1 (en) Recombinant protein
GB201203944D0 (en) Binding polypeptides
GB201204065D0 (en) Fusion polypeptide
GB201214293D0 (en) Binding surfaces
GB201210286D0 (en) Recombinant polypeptide
GB201211503D0 (en) Heparin binding peptides
GB201103961D0 (en) Binding polypeptides